Grutter Giorgia, Alfieri Sara, Parisi Francesco
Cardiology and Cardiac Surgery Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Cardiol Young. 2013 Jun;23(3):447-9. doi: 10.1017/S1047951112001047. Epub 2012 Jul 9.
The present study assessed the usefulness of brain natriuretic peptide in evaluating the cardiovascular status in children and grown-ups with congenital or acquired disease affected by chronic cardiac failure. Brain natriuretic peptide should be included in the risk stratification of children with dilated cardiomyopathy. In patients with congenital heart defects, it is useful to tailor the optimal medical strategy to individual patients.
本研究评估了脑钠肽在评估患有先天性或后天性疾病且受慢性心力衰竭影响的儿童和成人心血管状况方面的作用。脑钠肽应纳入扩张型心肌病患儿的风险分层。对于先天性心脏缺陷患者，根据个体患者情况制定最佳治疗策略是有用的。
